teravolt: thoracic cancers indicate an unexpectedly high mortality rate in patients with covid-19
Published 4 years ago • 50 plays • Length 7:12Download video MP4
Download video MP3
Similar videos
-
2:25
the impact of covid-19 in thoracic cancer patients: first results from the teravolt registry
-
3:04
teravolt: outcomes for patients with covid-19 and lung cancer
-
8:36
researcher comment: the teravolt findings | leora horn
-
7:37
clinical impact of covid-19 on patients with cancer: data from the covid-19 and cancer consortiu...
-
1:31
the impact of cancer treatment on covid-19 mortality
-
1:21:39
the right valve choice for tavi patient longevity and durability - europcr 2022
-
21:55
dr christian frezza - mitochondrial dysfunction in cancer
-
39:06
what is transcatheter aortic valve replacement? | william suh | uclamdchat
-
31:30
excess deaths: causes (deep dive)
-
1:52
coronavirus: excess deaths suggest a higher mortality rate than official figures
-
9:00
covid-19, cancer and comorbidities: a deadly triumvirate | mark lawler | tedxqueensuniversitybelfast
-
0:48
evaluating the safety of t-dxd with radiotherapy in her2 metastatic breast cancer
-
1:44
covid-19 and remnant ablation
-
2:32
increasing evidence erythritol raises risk of heart attack and stroke
-
1:47
safe: cardiotoxicity prevention in breast cancer treated with anthracyclines and/or trastuzumab
-
2:08
dr. becerra discusses regorafenib dosing in metastatic crc
-
7:09
tct 2021: partner 3: tavr is cost effective compared with savr for low-risk patients
-
3:29
turn the tide on lung cancer - accelerating lung cancer reform
-
56:19
optimal thyrotropin for thyroid cancer patients with dr. lindsay bischoff
-
25:23
tavr: evolution and vascular implications
-
3:37
dr. wirth discusses the results of the select trial in thyroid cancer
-
1:45
heart healthy minute: what is tavr?